Drug standards to be used in screening and analysis testing for suspected drug use in service member blood, urine and/or tissue testing.
Ended Awarded
- Contract number
- HT009025FG0910029
- Awardee
-
Cerilliant Corporation UEI JDDKSJ34EBZ7
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $21,685
Award facts
- Contract value 100% obligated
- $21,685.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325199 All Other Basic Organic Chemical Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Round Rock, TX 78665, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $21,685.45 firm fixed price Blank Purchase Agreement (BPA) call to Cerilliant Corporation for drug standards to be used in screening and analysis testing for suspected drug use in service member blood, urine, and/or tissue testing. This contract, which was not issued under any set-aside designation, leverages Cerilliant's established Indefinite Delivery Vehicle with the Defense Health Agency—a $250,000 BPA for drug reference standards and laboratory supplies extending through September 2028. The work will be performed at Cerilliant's facility in Round Rock, Texas, with an ultimate completion date of September 30, 2025.
Cerilliant Corporation, a global leader in certified reference materials and laboratory supplies headquartered in Round Rock, Texas, specializes in providing high-quality chemical and biological reference standards to defense and health-related organizations. As a foreign-owned manufacturer, the company has established a strong track record with federal agencies including the Defense Health Agency, Centers for Disease Control and Prevention, National Institutes of Health, and the Department of the Army Medical Command. This contract supports the Defense Health Agency's mission to provide comprehensive health services to service members by supplying critical drug reference materials necessary for toxicology screening and confirmation testing across the military healthcare system.
Quick answers
Who was awarded contract HT009025FG0910029?
HT009025FG0910029 was awarded to Cerilliant Corporation by Defense Health Agency (Department of Defense) on September 3, 2025.
How much is contract HT009025FG0910029 worth?
The government has obligated $21,685 on HT009025FG0910029.
Is contract HT009025FG0910029 an order under another contract?
Yes. HT009025FG0910029 is a BPA call under HT942523A0001, a blanket purchase agreement.
Was contract HT009025FG0910029 competed?
The extent of competition for HT009025FG0910029 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award